表紙:自動微生物検査の世界市場(2022年~2029年)
市場調査レポート
商品コード
1074116

自動微生物検査の世界市場(2022年~2029年)

Global Automated Microbiology Market - 2022-2029

出版日: | 発行: DataM Intelligence | ページ情報: 英文 180 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
自動微生物検査の世界市場(2022年~2029年)
出版日: 2022年05月07日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の自動微生物検査市場について調査分析し、市場力学、業界分析、市場分析、競合情勢など、体系的な情報を提供しています。

目次

第1章 世界の自動微生物検査市場の調査手法と範囲

  • 調査手法
  • 調査の目的と調査範囲

第2章 世界の自動微生物検査市場-市場の定義と概要

第3章 世界の自動微生物検査市場-エグゼクティブサマリー

  • 市場の内訳:製品別
  • 市場の内訳:診断技術別
  • 市場の内訳:エンドユーザー別
  • 市場の内訳:地域別

第4章 世界の自動微生物検査市場-市場力学

  • 市場に影響を与える要因
    • 促進要因
    • 抑制要因
    • 市場機会
    • 影響分析

第5章 世界の自動微生物検査市場-業界分析

  • サプライチェーン分析
  • 価格分析
  • アンメットニーズ

第6章 世界の自動微生物検査市場-COVID-19分析

  • 市場のCOVID-19分析
    • COVID-19以前の市場シナリオ
    • 現在のCOVID-19の市場シナリオ
    • COVID-19以後の市場シナリオ/将来の市場シナリオ
  • COVID-19における価格の力学
  • 需要と供給のスペクトル
  • パンデミック時の市場に関連する政府のイニシアチブ
  • メーカーの戦略的イニシアチブ
  • 結論

第7章 世界の自動微生物検査市場:製品別

  • イントロダクション
    • 市場規模分析、および前年比成長分析(%):製品別
    • 市場魅力指数:製品別
  • 装置*
    • イントロダクション
    • 市場規模分析、100万米ドル(2020年~2029年)、および前年比成長分析(%)(2021年~2029年)
  • 自動培養システム
  • 微生物アナライザー
  • 試薬

第8章 世界の自動微生物検査市場:診断技術別

  • イントロダクション
    • 市場規模分析、および前年比成長分析(%):診断技術別
    • 市場魅力指数:診断技術別
  • DNA・RNAプローブテクノロジー*
    • イントロダクション
    • 市場規模分析、100万米ドル(2020年~2029年)、および前年比成長分析(%)(2021年~2029年)
  • DNAシーケンシング
  • 検出技術
  • モノクローナル抗体
  • 非同位体法
  • 放射性メソッド
  • 免疫学的検査

第9章 世界の自動微生物検査市場:エンドユーザー別

  • イントロダクション
    • 市場規模分析、および前年比成長分析(%):エンドユーザー別
    • 市場魅力指数:エンドユーザー別
  • 製薬およびバイオテクノロジー企業*
    • イントロダクション
    • 市場規模分析、100万米ドル(2020年~2029年)、および前年比成長分析(%)(2021年~2029年)
  • 臨床ラボ
  • その他

第10章 世界の自動微生物検査市場:地域別

  • イントロダクション
    • 市場規模分析、100万米ドル(2020年~2029年)、および前年比成長分析(%)(2021年~2029年):地域別
    • 市場魅力指数:地域別
  • 北米
  • 欧州
  • 南米
  • アジア太平洋
  • 中東とアフリカ

第11章 世界の自動微生物検査市場-競合情勢

  • 主な開発と戦略
  • 企業シェア分析
  • 製品のベンチマーク
  • 注目すべき主要企業のリスト

第12章 世界の自動微生物検査市場-企業プロファイル概要

  • Becton Dickinson and Company*
    • 企業概要
    • 製品ポートフォリオおよび説明
    • 主要ハイライト
    • 財務概要
  • Microbiology International
  • Thermo Fisher Scientific, Inc.
  • bioMerieux, Inc.
  • Cardinal Health
  • Beckman Coulter, Inc.
  • Merck KGaA
  • Rapid Micro Biosystems, Inc.
  • Clever Culture Systems
  • Zhuhai Meihua Medical Technology Ltd.

第13章 世界の自動微生物検査市場-DataM

  • 付録
  • 当社・アプリケーションについて
  • 問い合わせ先
目次
Product Code: DMBT4899

Market Overview

The "global automated microbiology market" is estimated to reach US$ XX million during the forecast period (2022-2029).

Automated microbiology is a cutting-edge technology for delivering more efficient, accurate, and timely test findings in microbiological research and development. Its quick results aid in detecting infections, including Ebola, chickenpox, smallpox, rubella, measles, mumps, influenza, and others. This technology automates crucial activities such as microbe separation, detection, categorization, and measurement in the biological, ecological, and food industries.

Market Dynamics

A New Era in Clinical Microbiology with Automation and Molecular Diagnostics is expected to drive market growth.

Testing approaches based on organism growth on various liquid and solid media are being phased out in favor of newer methods that improve the pace of organism identification while also increasing sensitivity and specificity. Most of these new techniques are based on nucleic hybridization and polymerase-chain-reaction technology. They range from single-organism or organism family identification to multiplexed syndromic panels, which can simultaneously examine for the presence of multiple suspect organisms based on the patient's symptoms. Similarly, the clinical microbiology laboratory now has access to a level of automation previously only seen in the clinical laboratory's chemistry and hematology departments. Moreover, When appropriately implemented into the laboratory process, these transitions have been found to improve patient care. Collectively, the clinical microbiology laboratory is coming into a new era of technology and patient care that will bring about dramatic changes to conventional testing and organism identification. Thus, the market is expected to drive in the forecast period from the above statements.

Restraint:

High costs and large footprints of these systems, and a scarcity of qualified personnel to operate them are the factors the market is expected to hamper in the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted healthcare systems and the market. Automated technologies assist in detecting infectious agents such as parasites, viroids, fungus, prions, bacteria, and viruses. For instance, the global COVID-19 tally topped 5 million in less than 5 months, indicating that diseases like COVID-19 create a huge demand for the automated sector. Also, the automated microbiology industry's expansion is spurred by the need for speedy results with high precision and growing health-related concerns. Additionally, the pandemic is interrupting the supply chain, and many companies will vary to other geographic regions in the future to ensure that products remain available and protect their supply chain. Thus, the COVID-19 pandemic has affected the market. However, the situation is expected to improve gradually in the forecast period.

Segment Analysis

Clinical Laboratories segment is expected to hold the largest market share in automated microbiology market

The clinical laboratories segment is expected to dominate in 2020. The segment's growth benefits because of COVID-19's quick growth worldwide, increased microbiological research and development, increased investments in laboratory infrastructure development, and a growing emphasis on clinical laboratory automation. Moreover, the clinical microbiology laboratory saves time and enhances laboratory quality management by reducing its time to generate findings. Thus, the market segment is expected to hold the largest market share in the forecast period from the above statements.

Geographical Analysis

North America region holds the largest market share in the global automated microbiology market

In 2020, North America accounted for the highest revenue share. The rising prevalence of infectious and chronic diseases, increased awareness of early disease diagnosis, increased microbiological research and development activities, technological advances in molecular diagnostics, and product launches by key players in the region are some of the factors due to which the market is expected to boost in the forecast period. For instance, according to the Centers for Disease Control and Prevention, it is estimated that On March 14, 2022, there were 81,174,677 cases and 993,811 deaths in the United States. Moreover, Becton, Dickinson and Company announced the BD Kiestra IdentifA system in November 2019. This solution accurately and efficiently prepares samples for microbiological identification. Therefore, it has increased the demand for automated microbiology instruments or analyzers in the region. Thus, the North American region is expected to hold the largest market share in the forecast period from the above statements.

Competitive Landscape

Major key players in the automated microbiology market are Becton Dickinson and Company, Microbiology International, Thermo Fisher Scientific, Inc., bioMerieux, Inc., Cardinal Health, Beckman Coulter, Inc., Merck KGaA, Rapid Micro Biosystems, Inc., Clever Culture Systems and Zhuhai Meihua Medical Technology Ltd.

Thermo Fisher Scientific:

Overview:

Thermo Fisher Scientific is an American company incorporated in 1956 and is based in Waltham, Massachusetts. The company offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and services worldwide. Moreover, the global team has more than 90,000 colleagues who deliver an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.

VersaTREK Automated Microbial Detection System: The VersaTrek 528 is an automated BC microbial detection system produced by ThermoScientific. It detects pressure changes due to gas consumption (O2) and production (CO2, N2, H2, etc.) by microorganisms in a BC bottle. It is a more advanced and automated instrument than the single detection of CO2 production routinely used in several BC systems. It can detect bacterial pathogens that consume O2 without CO2 production. So it can provide a more credible and reliable result, improve recovery and reduce the TTDs of significant pathogens.

Why Purchase the Report?

Visualize the composition of the automated microbiology market segmentation by product, diagnostic technology, end user and region highlighting the key commercial assets and players.

Identify commercial opportunities in automated microbiology market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of automated microbiology market- level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

The global automated microbiology market report would provide an access to an approx. 45+market data table, 40+figures and 180 pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Table of Contents

1. Global Automated Microbiology Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Automated Microbiology Market - Market Definition and Overview

3. Global Automated Microbiology Market - Executive Summary

  • 3.1. Market Snippet by Product
  • 3.2. Market Snippet by Diagnostic Technology
  • 3.3. Market Snippet by End User
  • 3.4. Market Snippet by Region

4. Global Automated Microbiology Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. A New Era in Clinical Microbiology with Automation and Molecular Diagnostics is expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. High costs and large footprints of these systems and a scarcity of qualified personnel to operate them are the factors the market is expected to hamper in the forecast period.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Automated Microbiology Market - Industry Analysis

  • 5.1. Supply Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Unmet Needs

6. Global Automated Microbiology Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Automated Microbiology Market - By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product Segment
  • 7.2. Instruments*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Automated Culture Systems
  • 7.4. Microbiology Analyzers
  • 7.5. Reagents

8. Global Automated Microbiology Market - By Diagnostic Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Technology
    • 8.1.2. Market Attractiveness Index, By Diagnostic Technology Segment
  • 8.2. DNA & RNA Probe Technology*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. DNA sequencing
  • 8.4. Detection Techniques
  • 8.5. Monoclonal Antibodies
  • 8.6. Non-Isotopic Methods
  • 8.7. Radioactive Methods
  • 8.8. Immunoassays

9. Global Automated Microbiology Market - By End user

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 9.1.2. Market Attractiveness Index, By End user Segment
  • 9.2. Pharmaceutical and Biotechnology Companies*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Clinical Laboratories
  • 9.4. Others

10. Global Automated Microbiology Market - By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Technology
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Technology
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Technology
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Technology
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Technology
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. Global Automated Microbiology Market - Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking
  • 11.4. List of Key Companies to Watch

12. Global Automated Microbiology Market- Company Profiles

  • 12.1. Becton Dickinson and Company*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Microbiology International
  • 12.3. Thermo Fisher Scientific, Inc.
  • 12.4. bioMerieux, Inc.
  • 12.5. Cardinal Health
  • 12.6. Beckman Coulter, Inc.
  • 12.7. Merck KGaA
  • 12.8. Rapid Micro Biosystems, Inc.
  • 12.9. Clever Culture Systems
  • 12.10. Zhuhai Meihua Medical Technology Ltd.

LIST NOT EXHAUSTIVE

13. Global Automated Microbiology Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Applications
  • 13.3. Contact Us